The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 8 February 2005, www.theannals.com, DOI 10.1345/aph.1E534.
The Annals of Pharmacotherapy: Vol. 39, No. 3, pp. 559-562. DOI 10.1345/aph.1E534
© 2005 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Köksal, A. S.
Right arrow Articles by Sahin, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Köksal, A. S.
Right arrow Articles by Sahin, B.

Propranolol-Exacerbated Mesenteric Ischemia in a Patient with Hyperthyroidism

Aydin Seref Köksal, MD

Specialist, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital, Ankara, Turkey

Oguz Üsküdar, MD

Research Fellow, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital

Seyfettin Köklü, MD

Specialist, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital

Osman Yüksel, MD

Specialist, Department of Gastroenterology, Numune Hospital, Ankara

Yavuz Beyazit, MD

Research Fellow, Department of Internal Medicine, Hacettepe Medicine Faculty, Ankara

Burhan Sahin, MD

Instructor, Department of Gastroenterology, Türkiye Yüksek Ihtisas Hospital

Reprints: Dr. Beyazit, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, 06100 Sihhiye, Ankara, Turkey, fax 90 312 305 2302, yavuzbeyaz{at}yahoo.com

OBJECTIVE: To report a case of acute mesenteric ischemia associated with the use of oral propranolol.

CASE SUMMARY: A 59-year-old white man was admitted to the hospital with chronic diarrhea and weight loss. The patient was diagnosed as having hyperthyroidism. Therapy with propylthiouracil 100 mg 3 times daily and propranolol 20 mg twice daily was initiated on an outpatient basis. The following day, the patient was readmitted to our hospital with increased abdominal pain and bloody diarrhea. Angiography revealed superior mesenteric artery occlusion. Antegrade aorta-mesenteric bypass surgery was performed for revascularization, and the patient was discharged 10 days after the surgery. The patient was well both clinically and endoscopically at a follow-up visit 8 months later.

DISCUSSION: Although mesenteric ischemia is a devastating illness of varied causes, drug-associated mesenteric ischemia is rarely seen. By decreasing cardiac output and selective vasodilatory receptor inhibition in the splanchnic circulation, propranolol can cause a decline in splanchnic blood flow. An objective causality assessment indicated that propranolol was the possible cause of the arterial occlusion.

CONCLUSIONS: Propranolol may rarely be associated with mesenteric ischemia. In cases of newly developed acute abdomen undergoing propranolol therapy, physicians should be aware of this rare and serious adverse reaction to this drug.

Key Words: hyperthyroidism, ischemic colitis, mesenteric ischemia, propranolol

Published Online, February 8, 2005. www.theannals.com, DOI 10.1345/aph.1E534


This article has been cited by other articles:


Home page
QJMHome page
M.K.-S. Leow, D.E.-K. Chew, M. Zhu, and P.-C. Soon
Thyrotoxicosis and acute abdomen--still as defying and misunderstood today? Brief observations over the recent decade
QJM, December 1, 2008; 101(12): 943 - 947.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2005 by Harvey Whitney Books Company.